Combination of lectures, discussion rounds, and group work on thematic case studies. Topics: Adjuvant systems, such as aluminum salts, oil-in-water emulsions, water-in-Oil emulsions, liposomes, PLGA particles, virosomes, QS21, TLR ligands) and preclinical and clinical development of adjuvanted vaccines
Good understanding of the different adjuvant systems and of the challenges of preclinical and clinical development of adjuvanted vaccines.
M3 Adjuvants and Vaccine Formulation
Who should apply
The course will be organized in collaboration with ENOVA, the European Network of Vaccine Adjuvants. ENOVA will sponsor 10 additional participants, selected via the separate ENOVA call for applications.
The course provides an overview of State-of-the-art adjuvant systems and addresses the preclinical and clinical development of adjuvanted vaccines.
1 November 2020
Q1 2021 (4 days)
Participant Nr.: 10